<p>MiaPaCa-2 cells were transfected and treated as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0179884#pone.0179884.g004" target="_blank">Fig 4A</a>. Forty-eight hours post-treatment, cell lysates and total RNA were prepared and analyzed by immunoblotting (A) and RT-PCR (B), respectively. Actin and <i>GAPDH</i> were used as a loading and an internal control, respectively.</p
<p>C9 cells were treated with DMSO (control) or TPA (100 ng/mL). Compared to the DMSO-treated sample...
<p>(<b>a</b>) OVCA 420 (p53 wild-type), OVCA 432 (p53 mutant), and SKOV3 (null p53) cells were treat...
<p>(A) U2OS cells were transfected with an empty vector or vector expressing the myc-tagged C223S mu...
<p>MiaPaCa-2 cells were transfected and treated as in <a href="http://www.plosone.org/article/info:d...
<p>MiaPaCa-2 cells were treated with DMSO, the indicated concentrations of SAHA or left untreated. F...
<p>MiaPaCa-2 (solid boxes), Panc-1 (grey boxes) and <i>p53</i>-proficient human breast cancer MCF-7 ...
<p>A: The mRNA level of <i>p53</i> in MCF-7 cells was detected by RT-PCR. <i>GAPDH</i> was used for ...
<p><i>A</i>. Cells were transfected with HA-actin or treated with Jas (50 nM) or CD (0.01 µg/ml) for...
<p>Cells were either not transfected or transfected with 100 nM p53 siRNA and then treated with 3 µM...
<p><i>A.</i> Cells were transfected with siRNA-cofilin or treated with Jas (50 nM) or CD (0.01 µg/ml...
<p><i>A.</i> U2OS cells transfected with HA-actin were treated with ETO (10 µM) or untreated as cont...
<p>(<b>A</b>) Forty-eight hours after transfecting BG-1 cells with Ctrl or GSK-3β siRNA as explained...
<p><b>A.</b> Quantitative PCR was performed of selected p53 transcriptional targets in wild-type cel...
<p>(<b>A and D</b>) qRT-PCR analysis of p53 mRNA level in HuH7 cell line following the indicated con...
<p><b>(A)</b> Cytosolic proteins were obtained from ZL34 or ZL55 cells, treated or not with 5 μM Pta...
<p>C9 cells were treated with DMSO (control) or TPA (100 ng/mL). Compared to the DMSO-treated sample...
<p>(<b>a</b>) OVCA 420 (p53 wild-type), OVCA 432 (p53 mutant), and SKOV3 (null p53) cells were treat...
<p>(A) U2OS cells were transfected with an empty vector or vector expressing the myc-tagged C223S mu...
<p>MiaPaCa-2 cells were transfected and treated as in <a href="http://www.plosone.org/article/info:d...
<p>MiaPaCa-2 cells were treated with DMSO, the indicated concentrations of SAHA or left untreated. F...
<p>MiaPaCa-2 (solid boxes), Panc-1 (grey boxes) and <i>p53</i>-proficient human breast cancer MCF-7 ...
<p>A: The mRNA level of <i>p53</i> in MCF-7 cells was detected by RT-PCR. <i>GAPDH</i> was used for ...
<p><i>A</i>. Cells were transfected with HA-actin or treated with Jas (50 nM) or CD (0.01 µg/ml) for...
<p>Cells were either not transfected or transfected with 100 nM p53 siRNA and then treated with 3 µM...
<p><i>A.</i> Cells were transfected with siRNA-cofilin or treated with Jas (50 nM) or CD (0.01 µg/ml...
<p><i>A.</i> U2OS cells transfected with HA-actin were treated with ETO (10 µM) or untreated as cont...
<p>(<b>A</b>) Forty-eight hours after transfecting BG-1 cells with Ctrl or GSK-3β siRNA as explained...
<p><b>A.</b> Quantitative PCR was performed of selected p53 transcriptional targets in wild-type cel...
<p>(<b>A and D</b>) qRT-PCR analysis of p53 mRNA level in HuH7 cell line following the indicated con...
<p><b>(A)</b> Cytosolic proteins were obtained from ZL34 or ZL55 cells, treated or not with 5 μM Pta...
<p>C9 cells were treated with DMSO (control) or TPA (100 ng/mL). Compared to the DMSO-treated sample...
<p>(<b>a</b>) OVCA 420 (p53 wild-type), OVCA 432 (p53 mutant), and SKOV3 (null p53) cells were treat...
<p>(A) U2OS cells were transfected with an empty vector or vector expressing the myc-tagged C223S mu...